|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: GARDNER DENVER INC, 10-Q, 2000-11-14 |
Next: SOLIGEN TECHNOLOGIES INC, 10QSB, EX-11.1, 2000-11-14 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-QSB
| [X] | QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2000
OR
| [ ] | TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from _______ to _______
1-12694
(Commission file number)
SOLIGEN TECHNOLOGIES, INC.
(Exact name of small business issuer as specified in its charter)
| Wyoming (State or other jurisdiction of incorporation or organization) |
95-4440838 (I.R.S. Employer Identification No.) |
| 19408 Londelius Street Northridge, California (Address of principal executive offices) |
91324 (Zip code) |
(818) 718-1221
(Issuer’s telephone number, including area code)
Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the issuer was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [x] No [ ]
Number of shares of issuer’s Common Stock outstanding as of November 10, 2000: 36,433,054
Transitional Small Business Disclosure Format: Yes [ ] No [x]
SOLIGEN TECHNOLOGIES, INC.
FORM 10-QSB
TABLE OF CONTENTS
| Part I. | FINANCIAL INFORMATION | ||
| Item 1. | Consolidated Financial Statements | 3 | |
| Consolidated Balance Sheets at September 30, 2000 (unaudited) and March 31, 2000 |
3 | ||
| Consolidated Statements of Operations for the six months ended September 30, 2000 and 1999 (unaudited) |
4 | ||
| Consolidated Statements of Cash Flows for the six months ended September 30, 2000 and 1999 (unaudited) |
5 | ||
| Notes to Consolidated Financial Statements | 6 | ||
| Item 2. | Management’s Discussion and Analysis of Financial Condition or Plan of Operation | 8 | |
| Part II. | OTHER INFORMATION | ||
| Item 4. | Submission of Matters to a Vote of Security Holders | 11 | |
| Item 6. | Exhibits and Reports on Form 8-K | 11 | |
| SIGNATURES | 12 |
PART I. FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements
SOLIGEN TECHNOLOGIES, INC.
CONSOLIDATED BALANCE SHEETS
| September 30, 2000 |
March 31, 2000 |
||||||
| (unaudited) | |||||||
| ASSETS | |||||||
| Current assets: | |||||||
| Cash | $ | 307,000 | $ | 515,000 | |||
| Accounts receivable, net | 1,009,000 | 1,246,000 | |||||
| Inventories | 94,000 | 66,000 | |||||
| Prepaid expenses | 78,000 | 58,000 | |||||
| Total current assets | 1,488,000 | 1,885,000 | |||||
| Property, plant and equipment | 2,742,000 | 2,726,000 | |||||
| Less: allowance for depreciation and amortization | 2,267,000 | 2,179,000 | |||||
| Net property, plant and equipment | 475,000 | 547,000 | |||||
| Other assets | 42,000 | 41,000 | |||||
| Total assets | $ | 2,005,000 | $ | 2,473,000 | |||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | |||||||
| Current liabilities: | |||||||
| Current portion of notes payable and revolving line of credit | $ | 575,000 | $ | 366,000 | |||
| Trade accounts payable | 291,000 | 307,000 | |||||
| Accrued payroll and related expenses | 205,000 | 218,000 | |||||
| Accrued expenses | 247,000 | 207,000 | |||||
| Deferred revenue | 66,000 | 61,000 | |||||
| Total current liabilities | 1,384,000 | 1,159,000 | |||||
| Notes payable and revolving line of credit, less current portion | — | 12,000 | |||||
| Total liabilities | 1,384,000 | 1,171,000 | |||||
| Series B redeemable preferred stock, no par value: | |||||||
| 8,425,000 shares authorized, 8,375,000 issued and outstanding | 1,529,000 | 1,538,000 | |||||
| Stockholders’ deficit: | |||||||
| Common stock, no par value: | |||||||
| 90,000,000 shares authorized | |||||||
| 36,433,054 issued and outstanding | 11,814,000 | 11,788,000 | |||||
| Accumulated deficit | (12,722,000 | ) | (12,024,000 | ) | |||
| Total stockholders’ deficit | (908,000 | ) | (236,000 | ) | |||
| Total liabilities and stockholders’ deficit | $ | 2,005,000 | $ | 2,473,000 | |||
The accompanying notes are an integral part of these financial statements.
SOLIGEN TECHNOLOGIES, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
| Three Months Ended September 30, |
Six Months Ended September 30, |
||||||||||||
| 2000 | 1999 | 2000 | 1999 | ||||||||||
| Revenues | $ | 1,851,000 | $ | 1,761,000 | $ | 3,443,000 | $ | 3,368,000 | |||||
| Cost of revenues | 1,308,000 | 1,369,000 | 2,515,000 | 2,399,000 | |||||||||
| Gross profit | 543,000 | 392,000 | 928,000 | 969,000 | |||||||||
| Operating expenses: | |||||||||||||
| Research and development | 371,000 | 315,000 | 760,000 | 595,000 | |||||||||
| Selling | 194,000 | 196,000 | 361,000 | 373,000 | |||||||||
| General and administrative | 242,000 | 236,000 | 484,000 | 440,000 | |||||||||
| Total operating expenses | 807,000 | 747,000 | 1,605,000 | 1,408,000 | |||||||||
| Loss from operations | (264,000 | ) | (355,000 | ) | (677,000 | ) | (439,000 | ) | |||||
| Other income (expense): | |||||||||||||
| Interest income | 2,000 | 16,000 | 6,000 | 18,000 | |||||||||
| Interest expense | (20,000 | ) | (62,000 | ) | (35,000 | ) | (103,000 | ) | |||||
| Other income | — | — | 10,000 | 3,000 | |||||||||
| Total other income (expense) | (18,000 | ) | (46,000 | ) | (19,000 | ) | (82,000 | ) | |||||
| Loss before provision for income taxes | (282,000 | ) | (401,000 | ) | (696,000 | ) | (521,000 | ) | |||||
| Provision for income taxes | — | — | 2,000 | — | |||||||||
| Net loss | $ | (282,000 | ) | $ | (401,000 | ) | $ | (698,000 | ) | $ | (521,000 | ) | |
| Basic and diluted loss per share | $ | (0.01 | ) | $ | (0.01 | ) | $ | (0.02 | ) | $ | (0.02 | ) | |
The accompanying notes are an integral part of these financial statements.
SOLIGEN TECHNOLOGIES, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
| Six Months Ended September 30, |
|||||||
| 2000 | 1999 | ||||||
| Cash flows from operating activities: | |||||||
| Net loss | $ | (698,000 | ) | $ | (521,000 | ) | |
| Adjustments to reconcile net loss to net cash used in operating activities | |||||||
| Depreciation and amortization | 88,000 | 158,000 | |||||
| Provision for doubtful accounts | (18,000 | ) | 11,000 | ||||
| Non-cash interest expense | — | 51,000 | |||||
| Non-cash compensation expense | — | 37,000 | |||||
| (Increase) decrease in: | |||||||
| Accounts receivable | 255,000 | (142,000 | ) | ||||
| Inventories | (28,000 | ) | 19,000 | ||||
| Prepaid expense and other current assets | (21,000 | ) | (26,000 | ) | |||
| Increase (decrease) in: | |||||||
| Accounts payable | (16,000 | ) | 102,000 | ||||
| Accrued expenses | 27,000 | 52,000 | |||||
| Deferred revenues | 5,000 | 47,000 | |||||
| Net cash used for operating activities | (406,000 | ) | (212,000 | ) | |||
| Cash flows from investing activities: | |||||||
| Purchase of property, plant and equipment | (16,000 | ) | (92,000 | ) | |||
| Net cash used for investing activities | (16,000 | ) | (92,000 | ) | |||
| Cash flows from financing activities: | |||||||
| Net payments on capital lease obligations | — | (17,000 | ) | ||||
| Payments on notes payable | (9,000 | ) | (21,000 | ) | |||
| Net proceeds under revolving line of credit | 206,000 | 110,000 | |||||
| Proceeds from issuance of notes payable | — | — | |||||
| Proceeds from issuance of common stock | 17,000 | — | |||||
| Net cash provided by financing activities | 214,000 | 72,000 | |||||
| Net increase (decrease) in cash | (208,000 | ) | (232,000 | ) | |||
| Cash—beginning of period | 515,000 | 429,000 | |||||
| Cash—end of period | $ | 307,000 | $ | 197,000 | |||
The accompanying notes are an integral part of these financial statements.
SOLIGEN TECHNOLOGIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Basis of Presentation
The financial information included herein for the three and six month periods ended September 30, 2000 and 1999 is unaudited; however, such information reflects all adjustments consisting only of normal recurring adjustments which are, in the opinion of management, necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods. The financial information as of March 31, 2000, is derived from Soligen Technologies, Inc.’s Annual Report on Form 10-KSB for the fiscal year ended March 31, 2000. The interim consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s 2000 Form 10-KSB.
The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the full year.
Accounting Policies
Reference is made to Note 1 of Notes to Financial Statements in the Company’s Annual Report on Form 10-KSB for the fiscal year ended March 31, 2000 for the summary of significant accounting policies.
Inventories
Inventories are stated at the lower of cost or market on a first-in, first-out basis. Inventories consist of the following:
| September 30, 2000 |
||||
| Raw materials and parts | $ | 76,000 | ||
| Work in process | 12,000 | |||
| Finished goods | 6,000 | |||
| Total inventories | $ | 94,000 | ||
Deferred Revenue
Deferred revenue relates to the DSPC technology profit center. The deferred revenue related to machine revenues results mainly from the Company’ s issuance of licenses for the use of the machines, or to support the machines in the form of maintenance, rather than the outright sale of machines. Maintenance and license revenues are recognized using the straight-line method over the term of the agreement, which is generally over a period of 12 months.
Debt
Notes Payable
Notes payable at September 30, 2000 consisted of the following:
| Revolving line of credit, secured by certain assets bearing interest at the bank’s prime rate (9.50 percent at September 30, 2000) plus 3 percent |
$ 560,000 | |||
| Notes to finance companies, bearing interest ranging from 0.9 percent to 10.0 percent, due at various dates through October 2002 |
15,000 | |||
| Total notes payable | $ | 575,000 | ||
Preferred Stock
Series B Redeemable Convertible Preferred Stock
On November 24, 1999, the Company entered into a Series B Convertible Preferred Stock Purchase Agreement providing for the private placement of 8,425,000 shares of a newly authorized series of preferred stock (“Series B Preferred”). The Company received net proceeds of $1,538,000 from the sale of 8,425,000 shares of Series B Preferred to thirty-three (33) private investors (all of whom were accredited investors as defined in Regulation D) pursuant to the Stock Purchase Agreement. The purchasers of Series B Preferred also received Common Stock purchase warrants exercisable for a cumulative total of 3,622,750 shares of the Company’s Common Stock at an exercise price of $0.20 per share. These warrants are exercisable for a period of one year, commencing November 24, 1999. The financing was completed in accordance with the exemption provide d by Rule 506 of Regulation D.
In connection with the Series B financing, the Company paid a cash finder’s fee in the approximate amount of $100,000. In addition, the finders received warrants exercisable for 498,750 shares of Common Stock at a price of $0.20 per share. These warrants are exercisable for a period of one year, commencing November 24, 1999.
At a special stockholders meeting held on April 20, 1998, the Company’s stockholders approved an amendment to the Company’s Articles of Incorporation authorizing the issuance of up to 10,000,000 shares of preferred stock. This amendment authorizes the Company’s Board of Directors to issue preferred stock in one or more series on terms approved by the Board of Directors without the necessity of further action or approval by the stockholders. Pursuant to this authority, the Company’s Board of Directors has authorized the issuance of up to 8,425,000 shares of Series B Preferred Stock having rights and preferences as set forth in a Statement of Rights and Preferences filed with the Secretary of State of Wyoming on November 23, 1999. The following is a summary of certain terms of the Series B Preferred, and reference is made to the Statement for a complete desc ription of the rights and preferences of the Series B Preferred.
The Series B Preferred is not entitled to any fixed or guaranteed dividend. Upon a liquidation of the Company, the Series B Preferred is entitled to receive a distribution of $0.20 per share in preference to any distribution to holders of Common Stock or junior preferred stock. The approval of the holders of at least two-thirds of the outstanding shares of Series B Preferred is required for certain significant corporate actions, including mergers and sales of substantially all of the Company’s assets.
Each share of Series B Preferred is initially convertible into one share of the Company’s Common Stock, subject to adjustment for recapitalizations, stock splits and similar events. Subject to certain exceptions, the Series B conversion ratio is subject to adjustment in the event the Company issues shares of Common Stock for no consideration or for a consideration less than the fair market value of the Common Stock as of the date of such issuance. The Series B Preferred automatically converts into Common Stock in the event the average trading price of the Company’s Common Stock over 60 consecutive trading days is greater than $1.00 per share and the cumulative trading volume during such 60 day period is at least 1,000,000 shares, if traded on a national securities exchange, or 1,500,000 shares if traded on NASDAQ or over-the-counter. The Series B Preferred also au tomatically converts into Common Stock in the event the Company completes an underwritten public offering in which the Company receives gross proceeds of at least $10,000,000 and at a per share price of at least $1.00 per share (subject to adjustment for stock splits, recapitalizations, etc.).
The holders of Series B Preferred may tender their shares for redemption at a per share price equal to 150% of the liquidation preference in the event of a Change of Control (as defined in the Statement). In addition, the Company may, at its option, redeem the Series B Preferred at a per share price equal to 150% of the liquidation preference in the event that, from and after November 24, 2000, the Common Stock trades above $0.75 per share for sixty (60) consecutive trading days. During the quarter ended September 30, 2000, one investor converted 50,000 shares of Series B Preferred into 50,000 shares of the Company’s Common Stock.
Purchasers of Series B Preferred are also parties to an Investor Rights Agreement which grants certain demand and “piggyback” registration rights. The holders of Series B Preferred, voting as a separate class, are entitled to elect one member of the Company’s Board of Directors.
Item 2. Management’s Discussion and Analysis of Financial Condition or Plan of Operation
Forward-Looking Statements and Associated Risks
This Quarterly Report on Form 10-QSB contains certain forward-looking statements. These forward-looking statements are based largely on the Company’s current expectations and are subject to a number of risks and uncertainties including, among others (i) customer acceptance of the Company’s “one stop shop” Parts Now program; (ii) the possible emergence of competing technologies; and (iii) depending on results of operations, the Company’s ability to obtain additional financing required to continue its operations. Actual results could differ materially from these forward-looking statements. In view of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this Quarterly Report on Form 10-QSB will in fact transpire.
The following discussion should be read in conjunction with the accompanying Financial Statements of Soligen Technologies, Inc (“STI”) and its wholly-owned subsidiary Soligen, Inc. (“Soligen”) (collectively referred to herein as the “Company”) including the notes thereto, included elsewhere in this Quarterly Report.
Overview
Soligen holds an exclusive world-wide license from MIT until October 1, 2006 to develop, manufacture, market and sell products utilizing certain patented technology and processes for the production of ceramic casting molds for casting metal parts. The license continues on a non-exclusive basis thereafter until the expiration of the last patent relating to the licensed technology. The exclusive period may be extended by mutual agreement of both parties.
Based upon the MIT patent, the Company developed a proprietary technology known as Direct Shell Production Casting (“DSPC®”), a process that is distinguished from typical rapid prototype systems that are characterized by the ability to rapidly produce non functional three dimensional representations of parts from Computer Aided Design (“CAD”) files. The DSPC technology is dedicated to metal casting; this technology enables the Company to produce functional cast metal parts thereby providing a substantial competitive advantage over existing producers by eliminating the need of time and labor spent on patterns and core boxes.
The Company uses CAD files obtained from customers to produce ceramic casting molds. Metal is then cast into the ceramic molds at a foundry to yield metal parts identical to the customer’s CAD files. The parts are cast either at the Company’s aluminum foundry, or at other foundries. Since the casting molds are made directly from the customer’s CAD files, the customer is free to concurrently experiment with different designs or alloys. To better and more quickly service its customers, the Company has established a Parts Now on-line service on the Company’s interactive Web site (www.partsnow.com) on the Internet. The Company also joined the automotive Intranet ANX which enables Soligen direct access to CAD data at the Big Three automotive companies in the USA and some of their Tier 1 suppliers. Customer’s CAD files can also be transmitted by modem, Internet FTP protocols or del ivery of a standard data disk or tape.
DSPC also provides for a paradigm shift by enabling customer’s engineers to postpone the design and/or the fabrication of a production casting tooling that is normally used for manufacturing a limited number of metal parts. Functional metal parts provided by DSPC accomplish not only cost savings for the customer’s engineer but will also allow him to functionally test a metal part in the shortest time possible before going into production. This testing and proof of design of production tooling with very little chance of error provides significant time savings which in turn accomplishes a prime goal of the manufacturer, i.e., the reduction in “Time to Market.”
In addition to capitalizing on the advantages of DSPC prototypes and rapidly produced bridging production, the DSPC system can also produce high volume production tooling (usually made of steel). Future plans for the Company include establishment of rapid response production facilities either owned by the Company or licensed third parties for small to medium sized runs as well as a network of alliances or joint ventures with mass production foundries operating licensed DSPC centers. These DSPC centers will enable mass manufacturers to better participate in concurrent engineering programs with their customers together with their ability to cast near net shape production tooling for efficient manufacturing of production tooling. By establishing these networks of DSPC centers, the Company will provide manufacturers a seamless transition from CAD file to finished production parts. This network will operate un der the trade name Parts Now®. The Company’s first rapid response production facility consists of its
aluminum foundry and machine shop located in Santa Ana, California and a DSPC production center located at the Company’s headquarters in Northridge, California.
The Company’s revenues are classified as four major revenue-generating product lines:
1. Parts Now Service: This product line includes the “one stop shop” production services from receipt of the customer’s CAD file through production. Parts Now programs include any contract which may consist of a combination of DSPC, conventional casting and CNC machining expertise. Each Parts Now program is handled by a program / project engineer who oversees the transition from CAD to first article, to tooling, to conventional casting, finish machining and later, when applicable, to mass production.
2. DSPC Production Service: Revenues for this product line result from using the DSPC process in the production and sale of first article prototypes and short run quantities of cast metal parts made exclusively by DSPC directly from the customer’s CAD file.
3. Conventional Production Parts Service: Revenues for this product line are limited to conventional casting and machining of aluminum parts at the Company’s aluminum foundry and machine shop in Santa Ana, CA. Conventional production parts service line does not utilize DSPC or DSPC made tooling, and does not involve program management. In this category the Company is able to apply lower overhead margins and therefore capture additional business.
4. DSPC Technology Service: Revenues for this product line result from the sale, lease, license or maintenance of DSPC machines and from participation in research and development projects wherein the Company provides technological expertise.
Results of Operations
Revenues for the three and six months ended September 30, 2000 and 1999 were as follows:
| Three Months Ended September 30, |
Six Months Ended September 30, |
||||||||||||
| 2000 | 1999 | 2000 | 1999 | ||||||||||
| Parts Now® | $ | 1,313,000 | $ | 1,160,000 | $ | 2,414,000 | $ | 2,062,000 | |||||
| DSPC® production | 355,000 | 336,000 | 594,000 | 759,000 | |||||||||
| Conventional production parts | 181,000 | 239,000 | 433,000 | 496,000 | |||||||||
| DSPC® technology | 2,000 | 26,000 | 2,000 | 51,000 | |||||||||
| Total revenues | $ | 1,851,000 | $ | 1,761,000 | $ | 3,443,000 | $ | 3,368,000 | |||||
Revenues increased 5% to $1,851,000 for the quarter ended September 30, 2000 from $1,761,000 in the similar quarter last year and increased 2% to $3,443,000 for the six months ended September 30, 2000 from $3,368,000 for the similar six month period last year. Combined revenues for Parts Now and DSPC increased 11% to $1,668,000 for the quarter ended September 30, 2000 from $1,496,000 in the similar quarter ended last year and increased 7% to $3,008,000 for the six month period ended September 30, 2000 from $2,821,000 for the similar period last year. For the quarter ended September 30, 2000, conventional production parts revenues (Santa Ana division) decreased 24% to $181,000 from $239,000 for the similar quarter last year and for the six month period ended September 30, 2000 decreased 13% to $433,000 from $496,000 for the similar period last year. DSPC technology revenues we re $2,000 in the quarter ended September 30, 2000 compared to $26,000 in the quarter ended September 30, 1999 and $2,000 for the six months ended September 30, 2000 compared to $51,000 for the comparable six month period a year ago.
Gross profit for the quarter ended September 30, 2000 was $543,000 or 29% as compared to $392,000 or 22% for the similar quarter last year. The increase in gross margins was primarily the result of a reduction in material costs due to completing more secondary operations in the Company’s facility. Gross profit for the six months ended September 30, 2000 was $928,000 or 27% as compared to $969,000 or 29% for the similar six month period last year. The reduction in gross margin was primarily the result of hiring additional personnel in the quarter ended June 30, 2000 in anticipation of increased revenues. The increased wages were partially offset by the reduction in cost of materials in the quarter ended September 30, 2000. New personnel require intensive and lengthy training before they can participate effectively in the technologically demanding proprietary processes of the Compan y.
Research and development expenses increased to $371,000 for the quarter ended September 30, 2000 from $315,000 for the similar quarter ended last year and increased to $760,000 for the six months ended September 30, 2000 compared to $595,000 in the similar six month period a year ago. Increases were primarily the result of the addition of professional personnel in support of the introduction of new programs to satisfy the requirements of the complex and more demanding requirements of the automotive industry. The Company intends to continue the advancement of DSPC technology and its applications in the market place.
Selling expenses decreased to $194,000 for the quarter ended September 30, 2000 from $196,000 in the similar quarter last year and decreased to $361,000 for the six months ended September 30, 2000 from $373,000 in the similar period last year.
General and administrative expenses increased 3% to $242,000 for the quarter ended September 30, 2000 from $236,000 in the similar quarter ended last year and increased 10% to $484,000 for the six months ended September 30, 2000 from $440,000 for the similar period last year. The increase was the result of a reallocation of royalties and the allocation of certain wages that were previously categorized as manufacturing expenses.
Interest expenses were $20,000 and $62,000 for the quarters ended September 30, 2000 and 1999, respectively and $35,000 and $103,000, for the six months ended September 30, 2000 and 1999, respectively. The Company issued warrants to the short-term debt investors and, according to SFAS No. 123, non-cash interest expense related to the warrants is to be recognized over the expected period of the loan. As a result, the Company recognized $25,000 non-cash interest in the quarter ended September 30, 1999 with no similar expense incurred in the quarter ended September 30, 2000 and $51,000 non-cash interest for the six months ended September 30, 1999 with no similar expense incurred in the six months ended September 30, 2000. An additional $20,000 and $37,000 cash interest expense was incurred for the quarters ended September 30, 2000 and 1999, respectively and $35,000 and $52,000, for the six months ended September 30, 2000 and 1999, respectively. The cash interest expense was incurred primarily for payments associated with the revolving line of credit.
Cash and Sources of Liquidity
At September 30, 2000, the Company had $1,316,000 in cash and net accounts receivable, a decrease of $445,000 as compared to cash and net accounts receivable of $1,761,000 at March 31, 2000. Working capital decreased to $104,000 during the quarter ended September 30, 2000 from $347,000 and $726,000 during the quarters ended June 30, 2000 and March 31, 2000, respectively. In November 1999, the Company received net proceeds of $1,538,000 from the sale of 8,425,000 shares of Series B Convertible Preferred Stock to thirty-three (33) private investors.
In August 2000, the Company renewed its $1 million revolving line of credit with its commercial lender, collateralized by accounts receivable, inventory and fixed assets. The credit facility provides for an advance rate of 80% of eligible accounts receivable. At September 30, 2000, the Company had $230,000 available to borrow.
In order to continue operations, the Company needs to obtain additional financing before the quarter ending March 31, 2001. The Company is in discussions with existing shareholders with regard to a Preferred Stock financing.
PART II. OTHER INFORMATION
Item 4. Submission of Matters to a Vote of Security
On August 25, 2000, the Company held its 2000 Annual Meeting of Shareholders, at which the following actions were taken:
1. The Common and Preferred Shareholders elected five nominees to the Board of Directors of the Company. The four Directors elected by the Common and Preferred Shareholders voting together were Yehoram Uziel, Mark E. Dowley, Kenneth T. Friedman and Patrick J. Lavelle (36,220,885, 36,207,085, 36,207,085 and 36,207,085 shares were voted in favor and 87,510, 101,310, 101,310 and 101,310 shares abstained from voting for each of the nominees named, respectively). With respect to the one director elected by the Series B Preferred Stock, one nominee, David F. Hadley was elected with 5,650,000 shares voted in favor and no shares abstained from voting.
2. The Shareholders approved an amendment to the Company’s 1993 Stock Option Plan to increase the aggregate number of shares of Common Stock that may be issued thereunder from 5,000,000 to 6,500,000 (33,924,667 voted in favor, 944,228 shares voted against and 1,389,500 shares abstained from voting on this proposal).
3. The Shareholders ratified the selection of Singer Lewak Greenbaum & Goldstein LLP as independent public accountants for the Company for the fiscal year ended March 31, 2001 (36,099,816 shares voted in favor, 190,779 shares voted against and 17,800 shares abstained from voting on this proposal).
Item 6. Exhibits and Reports on Form 8-K
(a) Exhibits: The following exhibits are filed as part of this report:
| Exhibit Number | Description | ||
| 11.1 | Computation of Net Loss Per Share | ||
| 27 | Financial Data Schedule for the Quarter Ended September 30, 2000 |
(b) Reports on Form 8-K.
None
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed by the undersigned thereunto duly authorized.
| SOLIGEN TECHNOLOGIES, INC. | |||
| Date: November 10, 2000 | By: | /s/ Yehoram Uziel | |
| Yehoram Uziel President, CEO and Chairman of the Board (Principal executive officer) |
| Date: November 10, 2000 | By: | /s/ Robert Kassel | |
| Robert Kassel Chief Financial Officer (Principal financial officer) |
12
|
|